A comprehensive view of Phase 2 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GSK announces positive results in Phase 2 study showing its investigational tuberculosis medicine GSK3036656 is well-tolerated and shows early effectiveness at a low daily dose for 14 days

Janssen announces new injectable Tremfya guselkumab data show a clinical response rate of about 80% in a Phase 2b induction study of adults with moderately to severely active ulcerative colitis; inflammatory bowel disease affects 1.6 million people in US

Pfizer makes US$35.0M equity investment in clinical-stage biotech firm Anokion; Anokion to use part of proceeds to advance KAN-101 celiac disease treatment into Phase 2 clinical development, with Pfizer supporting development efforts

Decibel Therapeutics initiates Phase 1-2 clinical trial of DB-OTO gene therapy developed with Regeneron intended to provide hearing to patients with congenital hearing loss due to otoferlin deficiency; trial to involve pediatric patients

United Kingdom : GSK announces positive headline results from PERLA, the phase II trial of Jemperli dostarlimab plus chemotherapy in patients with metastatic non-squamous non-small cell lung cancer

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count